Engin Gul
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
-
- Peptidase Inhibition and Analysis
- CAR-T cell therapy research
- Cancer Treatment and Pharmacology
Papers in
- Hematology 44
- Multiple Myeloma Research and Treatments 44
- Chronic Myeloid Leukemia Treatments 3
-
- Protein Degradation and Inhibitors 23
- Co-authors
- Donna Reece (38 shared papers)Darrell White (35 shared papers)Arleigh McCurdy (33 shared papers)Rami Kotb (34 shared papers)Martha Louzada (33 shared papers)Christopher P. Venner (31 shared papers)Hira Mian (22 shared papers)Richard LeBlanc (32 shared papers)
- Journals
- Blood (18 papers)European Journal Of Haematology (4 papers)Blood Cancer Journal (2 papers)British Journal of Haematology (2 papers)Transplantation and Cellular Therapy (1 paper)
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
Engin Gul
41 papers receiving 188 citations
Peers
Comparison fields: 5 of 24
- Hematology 157
- Oncology 79
- Molecular Biology 88
- Immunology 25
- Transplantation 3
Countries citing papers authored by Engin Gul
This map shows the geographic impact of Engin Gul's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Engin Gul with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Engin Gul more than expected).
Fields of papers citing papers by Engin Gul
This network shows the impact of papers produced by Engin Gul. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Engin Gul. The network helps show where Engin Gul may publish in the future.
Co-authors
The 25 scholars most cited alongside Engin Gul, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 44 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 18 | |
| 2 | 2021 | 17 | |
| 3 | 2021 | 12 | |
| 4 | 2021 | 12 | |
| 5 | 2022 | 12 | |
| 6 | 2023 | 11 | |
| 7 | 2019 | 10 | |
| 8 | 2020 | 8 | |
| 9 | 2021 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2008 | 6 | |
| 12 | 2020 | 6 | |
| 13 | 2009 | 5 | |
| 14 | 2020 | 5 | |
| 15 | 2021 | 4 | |
| 16 | 2022 | 4 | |
| 17 | 2019 | 4 | |
| 18 | 2023 | 3 | |
| 19 | 2019 | 3 | |
| 20 | 2018 | 3 |
About Engin Gul
Engin Gul is a scholar working on Hematology, Molecular Biology, Oncology, Genetics and Cancer Research, having authored 44 papers that have together received 195 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (44 papers), Protein Degradation and Inhibitors (23 papers), Cancer Treatment and Pharmacology (12 papers), Peptidase Inhibition and Analysis (10 papers), Chronic Lymphocytic Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer Mechanisms and Therapy (2 papers) and Synthesis and Biological Activity (2 papers). The work is most often cited by research in Hematology (157 citations), Oncology (79 citations), Molecular Biology (88 citations), Immunology (25 citations) and Transplantation (3 citations). Engin Gul has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Donna Reece, Darrell White, Arleigh McCurdy, Rami Kotb, Martha Louzada, Christopher P. Venner, Hira Mian, Richard LeBlanc, Michaël Sébag and Tony Reiman. Their work appears in journals such as Blood, European Journal Of Haematology, Blood Cancer Journal, British Journal of Haematology and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.